SORBI, Claudia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.578
EU - Europa 4.709
AS - Asia 3.492
SA - Sud America 562
AF - Africa 110
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 4
Totale 16.485
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.424
IT - Italia 1.094
GB - Regno Unito 1.055
SG - Singapore 1.011
CN - Cina 878
SE - Svezia 644
DE - Germania 605
VN - Vietnam 463
HK - Hong Kong 448
BR - Brasile 432
FI - Finlandia 296
RU - Federazione Russa 229
FR - Francia 183
UA - Ucraina 125
IN - India 114
KR - Corea 114
TR - Turchia 104
BE - Belgio 92
CA - Canada 84
NL - Olanda 71
BG - Bulgaria 70
ID - Indonesia 55
IE - Irlanda 50
MX - Messico 43
JP - Giappone 40
AR - Argentina 39
BD - Bangladesh 39
PL - Polonia 37
RO - Romania 33
LT - Lituania 29
IQ - Iraq 28
IR - Iran 28
EC - Ecuador 24
NZ - Nuova Zelanda 23
AT - Austria 22
EG - Egitto 22
ES - Italia 21
ZA - Sudafrica 19
AE - Emirati Arabi Uniti 18
TW - Taiwan 18
CL - Cile 17
IL - Israele 17
CO - Colombia 16
VE - Venezuela 14
PK - Pakistan 13
KE - Kenya 12
NO - Norvegia 11
CH - Svizzera 10
KZ - Kazakistan 10
MA - Marocco 10
MY - Malesia 10
TH - Thailandia 10
UZ - Uzbekistan 10
PH - Filippine 9
SA - Arabia Saudita 9
DZ - Algeria 8
TN - Tunisia 8
AU - Australia 7
CZ - Repubblica Ceca 7
NG - Nigeria 7
AZ - Azerbaigian 6
CI - Costa d'Avorio 6
JO - Giordania 6
NP - Nepal 6
NI - Nicaragua 5
PE - Perù 5
PY - Paraguay 5
UY - Uruguay 5
BO - Bolivia 4
BY - Bielorussia 4
DK - Danimarca 4
EU - Europa 4
JM - Giamaica 4
LB - Libano 4
PS - Palestinian Territory 4
SN - Senegal 4
AL - Albania 3
BH - Bahrain 3
CR - Costa Rica 3
ET - Etiopia 3
HN - Honduras 3
LU - Lussemburgo 3
UG - Uganda 3
AO - Angola 2
DO - Repubblica Dominicana 2
EE - Estonia 2
MM - Myanmar 2
OM - Oman 2
PR - Porto Rico 2
RS - Serbia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TG - Togo 2
AF - Afghanistan, Repubblica islamica di 1
BB - Barbados 1
BN - Brunei Darussalam 1
BZ - Belize 1
CG - Congo 1
CY - Cipro 1
DM - Dominica 1
Totale 16.463
Salva come PNG Salva come JPEG
Città #
Southend 644
Santa Clara 640
Singapore 626
Ashburn 618
Fairfield 519
Hong Kong 425
Chandler 389
Woodbridge 353
Ann Arbor 329
Munich 324
Chicago 304
San Jose 292
Hefei 282
Nyköping 280
Houston 273
Seattle 258
Jacksonville 224
New York 223
Helsinki 218
Beijing 202
Wilmington 191
Dearborn 189
Modena 189
Cambridge 187
Los Angeles 162
London 150
Ho Chi Minh City 146
Council Bluffs 118
Hanoi 104
Seoul 97
Brussels 91
Salt Lake City 83
The Dalles 78
Milan 77
Sofia 66
San Diego 62
Eugene 53
Princeton 53
Elk Grove Village 50
Lauterbourg 50
Dublin 47
Izmir 46
Orem 45
Bologna 44
São Paulo 42
Moscow 40
Tampa 40
Tokyo 37
Amsterdam 36
Buffalo 33
Da Nang 33
Fremont 33
Jakarta 33
Toronto 33
Dallas 31
Frankfurt am Main 28
Redwood City 28
Shanghai 27
Bremen 25
Warsaw 25
Auckland 23
Boardman 23
Mexico City 23
Turku 23
Rome 22
Sochi 22
Sterling 20
Yalova 20
Reggio Emilia 19
Brooklyn 18
Chennai 18
Mumbai 18
Augusta 17
Norwalk 17
Phoenix 17
Haiphong 16
Parma 16
Grafing 15
Jyväskylä 15
Philadelphia 15
Guangzhou 14
Montreal 14
San Francisco 14
Boston 13
Denver 13
Des Moines 13
Kent 13
Lancaster 13
Paris 13
Stockholm 13
Atlanta 12
Baghdad 12
Horia 12
Leawood 12
Manchester 12
Zanjan 12
Columbus 11
Dhaka 11
Falkenstein 11
Guayaquil 11
Totale 10.951
Salva come PNG Salva come JPEG
Nome #
1,3-Dioxolane-Based Ligands Incorporating a Lactam or Imide moiety: Structure-Affinity/Activity Relationship at alpha1–Adrenoceptor subtypes and at 5-HT1A Receptors 745
(2,2-difenil-[1,3]-diossolan-4ilmetil)-(3-fenil-propil)-ammina: nuovo agonista parziale del recettore serotoninergico 5-HT1A 639
1,3-Dioxane as a scaffold for potent and selective 5-HT1AR agonist with in-vivo anxiolytic, anti-depressant and anti-nociceptive activity 568
1,3-Dioxolane-Based Ligands as a Novel Class of Alpha1-Adrenoceptor Antagonists 507
1,3-Dioxolane-Based Ligands as Rigid Analogues ofNaftopidil: Structure–Affinity/Activity Relationships at a1and 5-HT1A Receptors 482
1,3-dioxolane-based ligands in the search for alpha1-adrenergic antagonists. 446
1,4-Dioxolane-triazaspirodecanone derivatives as nociceptin/orphanin FQ receptor ligands 444
(2,2-Diphenyl-[1,3]oxathiolan-5-ylmethyl)-(3-phenylpropyl)-amine: a Potent and Selective 5-HT1A Receptor Agonist 439
Enantiomeric resolution of [(2,2-diphenyl-1,3-dioxolan-4-yl)methyl](2-phenoxyethyl)amine, a potent α1and 5-HT1Areceptor ligand: an in vitro and computational study 436
Discovery of a new 5-HT1A receptor agonist, acting ‘in vivo’ in a rat model of anxiety and depression 425
A New and Versatile Synthesis of 1,3-Dioxan-5-yl-pyrimidine and Purine Nucleoside Analogues 386
Discovery Of New Sigma-2 Receptor Agonist Endowed With Antiproliferative Activity 364
A homology modelling-driven study leading to the discovery of the first mouse trace amine-associated receptor 5 (TAAR5) antagonists 357
Synthesis, biological evaluation and molecular modeling of 1-oxa-4-thiaspiro- and 1,4-dithiaspiro[4.5]decane derivatives as potent and selective 5-HT1A receptor agonists 337
Diastereoselective Synthesis of (1,3-Dioxan-4-yl)pyrimidine and Purin Nucleoside Analogues 331
Structure-Activity Relationship within a new series of σ1 and σ2 receptor ligands: identification of a novel σ2R agonist (BS148) with selective toxicity against metastatic melanoma 329
Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at α1 and 5-HT1A receptors 328
Synthesis of 6-O-methotrexylhyaluronan as a drug delivery system 326
Synthesis and structure-activity relationships of 1-aralkyl-4- benzylpiperidine and 1-aralkyl-4-benzylpiperazine derivatives as potent σ ligands 325
Discovery of a new series of 5-HT1A receptor agonists 318
Synthesis and biological evaluation of 1,3-dioxolane-based 5-HT 1A receptor agonists for CNS disorders and neuropathic pain 300
Investigation of the effect of different linker chemotypes on the inhibition of histone deacetylases (HDACs) 292
Synthesis, structural characterization and biological evaluation of 4′-C-methyl- and phenyl-dioxolane pyrimidine and purine nucleosides 288
BS148 Reduces the Aggressiveness of Metastatic Melanoma via Sigma-2 Receptor Targeting 284
DAT atypical inhibitors as novel antipsychotic drugs 274
Structure-activity relationship at alpha-adrenergic receptors within a series of imidazoline analogues of cirazoline 266
Exhaustive CoMFA and CoMSIA analyses around different chemical entities: A ligand-based study exploring the affinity and selectivity profiles of 5-HT1A ligands 265
Transacetalization of Acetals with Butane-1,2,4-triol Using Cobalt(II) Chloride and Chlorotrimethylsilane 262
Scouting Sigma Receptor Ligands As New Tools For The Treatment Of Neurodegenerative Diseases And Cancer 259
Synthesis, biological evaluation and molecular modelling of 1-oxa-4-thiaspiro- and 1,4-dithiaspiro[4.5]decane derivatives as potent and selective 5-HT1A receptor agonists 257
Synthesis and Structure-Activity Relationships of Triazaspirodecanone Derivatives as Nociceptin/Orphanin FQ Receptor Ligands 255
Synthesis of 5-Methyl-1,3-oxathiolane-based Nucleoside Analogues as Potential Antiviral Agents 251
Discovery of potent pyrrolo-pyrimidine and purine HDAC inhibitors for the treatment of advanced prostate cancer 245
Structure Activity Relationships at 5-HT1A receptors within a novel series of 4-alkyl-1-arylpiperazine derivatives 240
Identification of a Potent and Selective 5-HT1AReceptor Agonist with In Vitro and In Vivo Antinociceptive Activity 234
Effect of the rigidification of propranolol, a mixed β-adrenoceptor and 5-HT1AR antagonist 230
Pyrrolidine Derivatives as New Ligands for 5-HT1A Receptors 229
Novel Dithiolane-Based Ligands Combining Sigma and NMDA Receptor Interactions as Potential Neuroprotective Agents 227
Synthesis, enantiomeric separation and docking studies of spiropiperidine analogues as ligands of the nociceptin/orphanin FQ receptor 226
Synthesis, absolute configuration and antimuscarinic activity of the enantiomers of [1-(2,2-diphenyl-[1,3]dioxolan-4-yl)-ethyl]dimethyl-amine 221
Inhibitors of histone deacetylase 6 based on a novel 3-hydroxy-isoxazole zinc binding group 207
Constrained 1,4-dialkylpiperazines as monoamine transporters inhibitors for cocaine-related abuse 201
Synthesis, structural characterization and pharmacological evaluation of spiroxatrine analogs as potential nociceptin/orphanin FQ receptor ligands 199
Derivati 1,3-Diossanici come Antagonisti Muscarinici 197
Relazioni struttura-attività in una nuova serie di ligandi alpha1-adrenergici e 5-HT1A serotoninergici a struttura 2,2-difenil-[1,3]diossolanica 184
Spiroxatrine derivatives towards 5-HT1A receptor selectivity 182
Synthesis and structural characterization of spiroxatrine derivatives as potential non-peptide ligands for NOP receptor 180
Synthesis and biological evaluation of Hsp90/HDAC6 dual inhibitors bearing a 2-amino-pyrrolopyrimidine and purine scaffold as potential anticancer drugs to treat prostate cancer 177
Novel S1R agonists counteracting NMDA excitotoxicity and oxidative stress: A step forward in the discovery of neuroprotective agents 175
IDENTIFICATION OF POTENT 1,3-DIOXOLANE-BASED 5-HT1A RECEPTOR AGONISTS FOR THE TREATMENTS OF CNS DISORDERS AND PAIN 175
1,3-Dithiolane as a Privileged Scaffold in Bioactive Derivatives: Chiral Resolution and Assignment of Absolute Configuration 173
Nuova Serie di Ligandi Sigma a Struttura Piperazinica e Piperidinica 171
Synthesis and pharmacological evaluation of Spiroxatrine derivatives as potential ligands for NOP receptor 170
Effect of the replacement of the o-methoxyphenyl moiety with nitrogen-containing aromatic rings within N-phenyl-piperazine and phenoxy-ethylamine-based 1,3-dioxo/oxathio/dithiolanes as α1 and 5-HT1A receptor ligands 159
Structure-Activity Relationships at alpha1-Adrenoceptor Subtypes within a New Series of 1,3-Dioxolane Derivatives 141
TB62, A POTENT 5-HT1A SEROTONERGIC FULL AGONIST, ENDOWED WITH DUAL ANTINOCICEPTIVE AND ANXIOLITIC/ANTIDEPRESSANT ACTIVITY 128
Insights into the Structural Conformations of the Tau Protein in Different Aggregation Status 116
Farmaci attivi sul sistema nervoso adrenergico 84
Totale 16.656
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.904
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.904
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021191 0 0 0 0 0 0 0 0 0 0 129 62
2021/20221.192 64 106 77 90 49 95 38 65 175 86 206 141
2022/20231.406 221 168 114 151 147 163 42 107 163 46 59 25
2023/2024948 20 51 99 103 216 86 58 126 9 38 69 73
2024/20253.334 161 41 72 163 487 443 472 285 323 156 319 412
2025/20265.125 370 223 462 789 1.069 341 671 289 481 421 9 0
Totale 16.656